Skip to main content
. 2016 Aug 9;16:142. doi: 10.1186/s12886-016-0317-y

Fig. 1.

Fig. 1

Percentage of patients who received bilateral intravitreal anti-VEGF injections regardless of the time interval between bilateral injections, showing a significant difference between nAMD and DME (respectively 36 % vs. 48 % of patients, p <0.01)